Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Keil

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Annals of Hematology|January 14, 2026
Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney diseaseChristina Brummer, Katja Evert, Felix Keil, et al.
BMC Musculoskeletal Disorders|May 8, 2026
Gene expression and histological assessment of capsular fibrosis in post-traumatic shoulder stiffness following plate fixation of proximal humeral fractures: an exploratory pilot studyLeopold Henssler, Daniela Drenkard, Moritz Riedl, et al.
Anticancer Research|May 29, 2008
Chemotherapy in gastric cancerEwald Wöll, Alexander Devries, Wolfgang Eisterer, et al.
European Journal of Haematology|May 26, 2018
High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicityThomas Noesslinger, Michael Panny, Ralph Simanek, et al.
Current Rheumatology Reports|April 13, 2017
Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature ReviewBirgit A Mosheimer, Bastian Oppl, Shahin Zandieh, et al.
Ejhaem|September 2, 2022
Unusually swift response of relapsed Burkitt leukemia to R-DHAPDennis Christoph Harrer, Alexander Denk, Felix Keil, et al.
Transfusion|November 9, 2002
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioningNina Worel, Hildegard T Greinix, Felix Keil, et al.
Clinical Case Reports|May 3, 2021
CPX-351 (Vyxeos<sup>®</sup>) can cause severe rash in acute myeloid leukemia-A case reportRuth M Urbantat, Valentin Popper, Elisabeth Menschel, et al.
Transplantation|July 17, 2003
Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survivalFelix Keil, Erika Prinz, Karin Moser, et al.
Cancer Management and Research|August 16, 2013
Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapyLaura Merlini, Giacomo Cartenì, Stefano Iacobelli, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Annals of Hematology|January 14, 2026
Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney diseaseChristina Brummer, Katja Evert, Felix Keil, et al.
BMC Musculoskeletal Disorders|May 8, 2026
Gene expression and histological assessment of capsular fibrosis in post-traumatic shoulder stiffness following plate fixation of proximal humeral fractures: an exploratory pilot studyLeopold Henssler, Daniela Drenkard, Moritz Riedl, et al.
Anticancer Research|May 29, 2008
Chemotherapy in gastric cancerEwald Wöll, Alexander Devries, Wolfgang Eisterer, et al.
European Journal of Haematology|May 26, 2018
High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicityThomas Noesslinger, Michael Panny, Ralph Simanek, et al.
Current Rheumatology Reports|April 13, 2017
Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature ReviewBirgit A Mosheimer, Bastian Oppl, Shahin Zandieh, et al.
Ejhaem|September 2, 2022
Unusually swift response of relapsed Burkitt leukemia to R-DHAPDennis Christoph Harrer, Alexander Denk, Felix Keil, et al.
Transfusion|November 9, 2002
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioningNina Worel, Hildegard T Greinix, Felix Keil, et al.
Clinical Case Reports|May 3, 2021
CPX-351 (Vyxeos<sup>®</sup>) can cause severe rash in acute myeloid leukemia-A case reportRuth M Urbantat, Valentin Popper, Elisabeth Menschel, et al.
Transplantation|July 17, 2003
Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survivalFelix Keil, Erika Prinz, Karin Moser, et al.
Cancer Management and Research|August 16, 2013
Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapyLaura Merlini, Giacomo Cartenì, Stefano Iacobelli, et al.
Pageof 9